AAAP Annual meeting ad.
- Published in:
- 2022
- Publication type:
- Journal Article
Works matching IS 10550496 AND DT 2022 AND VI 31 AND IP 3
Results: 20
1
2
Call for abstracts workshops AJA 2022.
- Published in:
- 2022
- Publication type:
- journal article
3
Issue Information ‐ Editorial Board.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 165, doi. 10.1111/ajad.13302
- Publication type:
- Article
4
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 242, doi. 10.1111/ajad.13285
- By:
- Publication type:
- Article
5
Issue Information.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 163, doi. 10.1111/ajad.13301
- Publication type:
- Article
6
Issue Information ‐ ToC.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 167, doi. 10.1111/ajad.13303
- Publication type:
- Article
7
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 189, doi. 10.1111/ajad.13283
- By:
- Publication type:
- Article
8
AAAP Membership benefits.
- Published in:
- 2022
- Publication type:
- Journal Article
9
Call for special issue 2022.
- Published in:
- 2022
- Publication type:
- journal article
10
Call for review papers 2022.
- Published in:
- 2022
- Publication type:
- journal article
11
Associations between muscle‐building exercise and alcohol use behaviors among adolescent boys: Results from the 2019 Youth Risk Behavior Survey.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 251, doi. 10.1111/ajad.13284
- By:
- Publication type:
- Article
12
AAAP Membership podcast.
- Published in:
- 2022
- Publication type:
- journal article
13
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 236, doi. 10.1111/ajad.13282
- By:
- Publication type:
- Article
14
Trajectories of prescription opioid and heroin use in adulthood.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 180, doi. 10.1111/ajad.13281
- By:
- Publication type:
- Article
15
Outcomes associated with once‐daily versus multiple‐daily dosing of buprenorphine/naloxone for opioid use disorder.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 173, doi. 10.1111/ajad.13267
- By:
- Publication type:
- Article
16
Predictors of protein intake among people who inject drugs in Los Angeles and San Francisco, California.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 228, doi. 10.1111/ajad.13280
- By:
- Publication type:
- Article
17
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 256, doi. 10.1111/ajad.13268
- By:
- Publication type:
- Article
18
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 219, doi. 10.1111/ajad.13266
- By:
- Publication type:
- Article
19
Congenital syphilis prevention in the context of methamphetamine use and homelessness.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 210, doi. 10.1111/ajad.13265
- By:
- Publication type:
- Article
20
Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder.
- Published in:
- American Journal on Addictions, 2022, v. 31, n. 3, p. 200, doi. 10.1111/ajad.13258
- By:
- Publication type:
- Article